Thioridazine elicits potent antitumor effects in colorectal cancer stem cells
Chen Zhang et al, 2017 CrossRef
Activation of DRD5 (dopamine receptor D5) inhibits tumor growth by autophagic cell death
Zhi Gen Leng et al, 2017, Autophagy CrossRef
Psychotropic agent thioridazine elicits potent in vitro and in vivo anti-melanoma effects
Xiaoshuang Jiang et al, 2018, Biomedicine & Pharmacotherapy CrossRef
Low concentration trifluoperazine promotes proliferation and reduces calcium-dependent apoptosis in glioma cells
Yulin Wen et al, 2018, Sci Rep CrossRef
GEPSI: A Gene Expression Profile Similarity-Based Identification Method of Bioactive Components in Traditional Chinese Medicine Formula
Baixia Zhang et al, 2018, Evidence-Based Complementary and Alternative Medicine CrossRef
Antipsychotic dopamine receptor antagonists, cancer, and cancer stem cells
Md. Saiful Islam Roney et al, 2018, Arch. Pharm. Res. CrossRef
Down-regulation of intracellular anti-apoptotic proteins, particularly c-FLIP by therapeutic agents; the novel view to overcome resistance to TRAIL
Ali Hassanzadeh et al, 2018, J Cell Physiol CrossRef
DeCoST: A New Approach in Drug Repurposing From Control System Theory
Thanh M. Nguyen et al, 2018, Front. Pharmacol. CrossRef
Drug Repurposing Patent Applications January–March 2016
Hermann A.M. Mucke, 2016, ASSAY and Drug Development Technologies CrossRef
ROS mediated ER stress induces Bax-Bak dependent and independent apoptosis in response to Thioridazine
Mahendra Seervi et al, 2018, Biomedicine & Pharmacotherapy CrossRef
Thioridazine inhibits self-renewal in breast cancer cells via DRD2-dependent STAT3 inhibition, but induces a G₁ arrest independent of DRD2.
Matthew Tegowski et al, 2018, J Biol Chem CrossRef
Targeting the TLK1/NEK1 DDR axis with Thioridazine suppresses outgrowth of androgen independent prostate tumors
Vibha Singh et al, 2019, Int. J. Cancer CrossRef
Cancer and the Dopamine D2 Receptor: A Pharmacological Perspective
Jillian S. Weissenrieder et al, 2019, J Pharmacol Exp Ther CrossRef
Apparent Carbon Monoxide InsertionviaDouble Isocyanide Incorporation during Palladium-Catalyzed Construction of Indoloquinoline Ring in a Single Pot: Synthesis of New Cytotoxic Agents
Suresh Babu Nallapati et al, 2016, Adv. Synth. Catal. CrossRef
Association of Mental Health-Related Proteins DAXX, DRD3, and DISC1 With the Progression and Prognosis of Chondrosarcoma
Lile He et al, 2019, Front. Mol. Biosci. CrossRef
Selective Effects of Thioridazine on Self-Renewal of Basal-Like Breast Cancer Cells
Matthew Tegowski et al, 2019, Sci Rep CrossRef
In vitro and in vivo anti-tumor effects of brexpiprazole, a newly-developed serotonin-dopamine activity modulator with an improved safety profile
Shuhei Suzuki et al, 2019, Oncotarget CrossRef
AXL knockdown gene signature reveals a drug repurposing opportunity for a class of antipsychotics to reduce growth and metastasis of triple-negative breast cancer
Marie-Anne Goyette et al, 2019, Oncotarget CrossRef
DR2 blocker thioridazine: A promising drug for ovarian cancer therapy
Min Yong et al, 2017, Oncol Lett CrossRef
Generation of Phenothiazine with Potent Anti-TLK1 Activity for Prostate Cancer Therapy
Vibha Singh et al, 2020, iScience CrossRef
Thioridazine requires calcium influx to induce MLL-AF6–rearranged AML cell death
Claudia Tregnago et al, 2020 CrossRef
Preparation of Multifunctional Dopamine-Coated Zerovalent Iron/Reduced Graphene Oxide for Targeted Phototheragnosis in Breast Cancer
Chia-Hua Lin et al, 2020, Nanomaterials CrossRef
Increased dopamine and its receptor dopamine receptor D1 promote tumor growth in human hepatocellular carcinoma
Yan Yan et al, 2020, Cancer Communications CrossRef
Thioridazine hydrochloride: an antipsychotic agent that inhibits tumor growth and lung metastasis in triple-negative breast cancer via inducing G0/G1 arrest and apoptosis
Yanlin Song et al, 2020, Cell Cycle CrossRef
Penfluridol Represses Integrin Expression in Breast Cancer through Induction of Reactive Oxygen Species and Downregulation of Sp Transcription Factors
Erik Hedrick et al, 2017, Mol Cancer Ther CrossRef
null
Anne-Marie Ellegaard et al, 2020 CrossRef
The Comparative Effect of Nisin and Thioridazine as Potential Anticancer Agents on Hepatocellular Carcinoma
Noha El-Sayed Ibrahim et al, 2021, rbmb.net CrossRef
A Case Control Study on Serum Levels of Potential Biomarkers in Male Breast Cancer Patients
Kamal Eldin Ahmed Abdelsalam et al, 2021, IJERPH CrossRef
Cell cycle dependence on the mevalonate pathway: role of cholesterol and non-sterol isoprenoids
Miguel A. Lasunción et al, 2021, Biochemical Pharmacology CrossRef
Pathophysiologic Role of Neurotransmitters in Digestive Diseases
Xiaoxu Yang et al, 2021, Front. Physiol. CrossRef
Dopamine Receptors in Cancer: Are They Valid Therapeutic Targets?
Arely Rosas-Cruz et al, 2021, Technol Cancer Res Treat CrossRef
Trace Amine-Associated Receptor 1 (TAAR1) Is a Positive Prognosticator for Epithelial Ovarian Cancer
Tilman L. R. Vogelsang et al, 2021, IJMS CrossRef
The molecular mechanism of chronic stress affecting the occurrence and development of breast cancer and potential drug therapy
Hui-min Liu et al, 2022, Translational Oncology CrossRef
Drug Repurposing in Cancer Therapy: Influence of Patient’s Genetic Background in Breast Cancer Treatment
Rafaela Rodrigues et al, 2022, IJMS CrossRef
Possible involvement of apoptosis in the antipsychotics side effects: A mini‐review
Jana Osacka et al, 2022, Clin Exp Pharma Physio CrossRef
Treatment of Cancer with Antipsychotic Medications: Pushing the Boundaries of Schizophrenia and Cancer
James S. Brown, 2022, Neuroscience & Biobehavioral Reviews CrossRef
Dopamine receptor D3 is related to prognosis in human hepatocellular carcinoma and inhibits tumor growth
Yan Yan et al, 2022, BMC Cancer CrossRef
Voluntary wheel running reduces tumor growth and increases capillarity in the heart during doxorubicin chemotherapy in a murine model of breast cancer
Tytti-Maria Uurasmaa et al, 2024, Front. Physiol. CrossRef